ZEALAND PHARMA ANNOUNCES INITIATION OF THE PHASE 2 ZYNERGY TRIAL OF PETRELINTIDE CO-ADMINISTERED WITH ENICEPATIDE IN PEOPLE WITH OBESITY OR OVERWEIGHT

Reuters · 2d ago

Please log in to view news